圣湘生物 (688289.SH)
21.63 -0.27(-1.230%)
+ 收藏
今开:21.87 最高:21.99 成交量:2.87万手
昨收:21.90 最低:21.55 成交额:6235.74万
利润表(圣湘生物)
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
一、营业总收入(元) | 1,032,580,636.67 | 716,957,551.18 | 390,946,762.39 | 1,007,118,933.74 | 632,543,388.93 | 427,695,798.20 | 195,173,984.72 |
营业收入(元) | 1,032,580,636.67 | 716,957,551.18 | 390,946,762.39 | 1,007,118,933.74 | 632,543,388.93 | 427,695,798.20 | 195,173,984.72 |
二、营业总成本(元) | 888,194,458.51 | 586,952,044.77 | 296,325,586.08 | 981,841,369.32 | 649,562,487.47 | 432,733,363.67 | 208,212,898.93 |
营业成本(元) | 232,314,189.76 | 162,995,059.19 | 73,904,097.30 | 286,640,893.23 | 197,785,471.82 | 142,251,745.56 | 63,493,755.80 |
研发费用(元) | 189,915,613.99 | 117,616,680.71 | 55,402,242.13 | 196,275,570.41 | 137,493,724.89 | 90,521,955.62 | 46,345,922.89 |
营业税金及附加(元) | 7,536,727.57 | 4,820,402.23 | 2,358,171.97 | 4,646,049.09 | 1,727,637.98 | 2,386,214.38 | 1,144,619.55 |
销售费用(元) | 342,156,718.12 | 223,566,517.57 | 119,730,632.37 | 358,420,815.41 | 231,189,042.29 | 154,387,810.70 | 65,333,289.57 |
管理费用(元) | 176,534,426.64 | 118,798,228.11 | 61,961,457.17 | 189,312,341.10 | 122,390,928.98 | 75,773,373.91 | 33,350,762.34 |
财务费用(元) | -60,263,217.57 | -40,844,843.04 | -17,031,014.86 | -53,454,299.92 | -41,024,318.49 | -32,587,736.50 | -1,455,451.23 |
其中:利息费用(元) | 16,803,462.33 | 11,328,290.64 | 5,387,422.13 | 2,408,602.59 | 908,881.11 | 207,881.76 | 289,057.09 |
其中:利息收入(元) | 77,740,767.52 | 51,368,184.17 | 22,698,184.23 | 54,672,883.49 | 35,982,498.15 | 22,874,248.13 | 12,119,083.80 |
三、其他经营收益 | |||||||
加:公允价值变动收益(元) | 7,438,095.29 | 5,726,346.91 | 2,975,320.32 | 61,842,500.27 | 60,572,951.28 | 48,064,430.84 | 19,464,286.25 |
加:投资收益(元) | -28,614,110.00 | -34,229,360.64 | -16,888,538.69 | 253,737,455.45 | 241,992,279.47 | -12,577,064.62 | -7,032,951.50 |
其中:对联营企业和合营企业的投资收益(元) | -27,080,338.16 | -20,337,397.03 | -16,910,977.04 | -22,157,554.60 | -23,662,834.71 | -12,621,694.76 | -7,055,143.28 |
资产处置收益(元) | -1,899,035.23 | 216,607.24 | -63,499.97 | -247,879.07 | -85,490.12 | -301,220.26 | 29,061.80 |
资产减值损失(元) | 15,624,281.83 | 9,851,981.90 | 4,399,418.72 | 7,506,807.73 | 890,367.44 | 121,887.44 | 121,887.44 |
信用减值损失(元) | -1,781,600.92 | 4,230,394.08 | 1,714,609.02 | -446,864.34 | 14,092,317.24 | 16,494,678.41 | 8,877,060.44 |
其他收益(元) | 73,490,839.59 | 58,610,212.06 | 10,061,490.10 | 79,793,338.22 | 65,887,828.26 | 64,612,620.90 | 63,432,330.70 |
四、营业利润(元) | 208,644,648.72 | 174,411,687.96 | 96,819,975.81 | 427,462,922.68 | 366,331,155.03 | 111,377,767.24 | 71,852,760.92 |
加:营业外收入(元) | 383,788.53 | 199,834.37 | 108,782.06 | 1,518,902.91 | 1,460,011.99 | 1,277,603.60 | 5,246.90 |
减:营业外支出(元) | 8,822,619.89 | 6,313,461.50 | 4,596,366.91 | 18,503,647.24 | 15,668,024.07 | 4,609,702.87 | 1,420,963.88 |
五、利润总额(元) | 200,205,817.36 | 168,298,060.83 | 92,332,390.96 | 410,478,178.35 | 352,123,142.95 | 108,045,667.97 | 70,437,043.94 |
减:所得税费用(元) | 37,128,823.35 | 32,646,558.87 | 18,922,099.90 | 62,310,821.36 | 53,638,063.19 | 17,124,934.12 | 10,447,556.48 |
六、净利润(元) | 163,076,994.01 | 135,651,501.96 | 73,410,291.06 | 348,167,356.99 | 298,485,079.76 | 90,920,733.85 | 59,989,487.46 |
(一)按经营持续性分类 | |||||||
持续经营净利润(元) | 163,076,994.01 | 135,651,501.96 | 73,410,291.06 | 348,167,356.99 | 298,485,079.76 | 90,920,733.85 | 59,989,487.46 |
(二)按所有权归属分类 | |||||||
归属于母公司股东的净利润(元) | 195,427,005.64 | 156,705,803.45 | 81,024,703.84 | 363,721,131.71 | 299,723,558.25 | 91,676,113.08 | 60,012,907.11 |
少数股东损益(元) | -32,350,011.63 | -21,054,301.49 | -7,614,412.78 | -15,553,774.72 | -1,238,478.49 | -755,379.23 | -23,419.65 |
扣除非经常性损益后的净利润(元) | 151,321,455.27 | 121,128,936.53 | 73,755,740.91 | 71,649,353.76 | 20,526,130.22 | 31,180,554.75 | 3,576,794.25 |
七、每股收益 | |||||||
一、基本每股收益(元) | 0.34 | 0.27 | 0.14 | 0.62 | 0.51 | 0.16 | 0.10 |
二、稀释每股收益(元) | 0.33 | 0.26 | 0.14 | 0.62 | 0.51 | 0.16 | 0.10 |
八、其他综合收益(元) | -85,769,939.35 | -80,468,805.84 | 1,916,849.56 | -144,495,170.71 | -8,530,070.97 | 3,757,379.64 | -2,094,022.13 |
归属于母公司股东的其他综合收益(元) | -9,443,183.89 | -4,142,050.38 | 1,916,849.56 | -134,150,880.42 | -7,823,632.07 | 334,134.94 | -1,833,523.51 |
归属于少数股东的其他综合收益(元) | -76,326,755.46 | -76,326,755.46 | - | -10,344,290.29 | -706,438.90 | 3,423,244.70 | -260,498.62 |
九、综合收益总额(元) | 77,307,054.66 | 55,182,696.13 | 75,327,140.62 | 203,672,186.28 | 289,955,008.79 | 94,678,113.49 | 57,895,465.33 |
归属于母公司所有者的综合收益总额(元) | 185,983,821.75 | 152,563,753.08 | 82,941,553.40 | 229,570,251.29 | 291,899,926.18 | 92,010,248.02 | 58,179,383.60 |
归属于少数股东的综合收益总额(元) | -108,676,767.09 | -97,381,056.95 | -7,614,412.78 | -25,898,065.01 | -1,944,917.39 | 2,667,865.47 | -283,918.27 |
公告日期 | 2024-10-24 | 2024-08-19 | 2024-04-27 | 2024-04-27 | 2023-10-31 | 2023-08-17 | 2023-04-26 |
审计意见(境内) | 标准无保留意见 | ||||||
原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
上市前/上市后 |
报表类型 |
一、营业总收入(元) |
营业收入(元) |
二、营业总成本(元) |
营业成本(元) |
研发费用(元) |
营业税金及附加(元) |
销售费用(元) |
管理费用(元) |
财务费用(元) |
其中:利息费用(元) |
其中:利息收入(元) |
三、其他经营收益 |
加:公允价值变动收益(元) |
加:投资收益(元) |
其中:对联营企业和合营企业的投资收益(元) |
资产处置收益(元) |
资产减值损失(元) |
信用减值损失(元) |
其他收益(元) |
四、营业利润(元) |
加:营业外收入(元) |
减:营业外支出(元) |
五、利润总额(元) |
减:所得税费用(元) |
六、净利润(元) |
(一)按经营持续性分类 |
持续经营净利润(元) |
(二)按所有权归属分类 |
归属于母公司股东的净利润(元) |
少数股东损益(元) |
扣除非经常性损益后的净利润(元) |
七、每股收益 |
一、基本每股收益(元) |
二、稀释每股收益(元) |
八、其他综合收益(元) |
归属于母公司股东的其他综合收益(元) |
归属于少数股东的其他综合收益(元) |
九、综合收益总额(元) |
归属于母公司所有者的综合收益总额(元) |
归属于少数股东的综合收益总额(元) |
公告日期 |
审计意见(境内) |
原始财报文件下载 |
Showing 1 to 45 of 45 entries